The nexus of opioids, pain, and addiction: Challenges and solutions von Henningfield, Jack E., Ashworth, Judy B., Gerlach, Karen K., Simone, Bernie, Schnoll, Sidney H.

Volltext

REL-1017 (esmethadone; d-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley rats von Henningfield, Jack, Gauvin, David, Bifari, Francesco, Fant, Reginald, Shram, Megan, Buchhalter, August, Ashworth, Judy, Lanier, Ryan, Pappagallo, Marco, Inturrisi, Charles, Folli, Franco, Traversa, Sergio, Manfredi, Paolo L.

Volltext

Integration of genomic and clinical data augments surveillance of healthcare-acquired infections von Ward, Doyle V, Hoss, Andrew G, Kolde, Raivo, van Aggelen, Helen C, Loving, Joshua, Smith, Stephen A, Mack, Deborah A, Kathirvel, Raja, Halperin, Jeffery A, Buell, Douglas J, Wong, Brian E, Ashworth, Judy L, Fortunato-Habib, Mary M, Xu, Liyi, Barton, Bruce A, Lazar, Peter, Carmona, Juan J, Mathew, Jomol, Salgo, Ivan S, Gross, Brian D, Ellison, Richard T

Volltext

Accuracy of Infection Control Surveillance in Identifying Genomically Confirmed Cross Transmission Clusters von Hansen, Kyle, Ellison, Richard T., Ward, Doyle V., Holler, Devon J., Ashworth, Judy L., Fortunato-Habib, Mary M., Carmona, Juan J., Gross, Brian D.

Volltext

A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers von Vosburg, Suzanne K., Jones, Jermaine D., Manubay, Jeanne M., Ashworth, Judy B., Shapiro, Douglas Y., Comer, Sandra D.

Volltext

Assessment of a formulation designed to be crush-resistant in prescription opioid abusers von Vosburg, Suzanne K, Jones, Jermaine D, Manubay, Jeanne M, Ashworth, Judy B, Benedek, Irma H, Comer, Sandra D

Volltext

Precision Infection Prevention (PIP) as a New Standard of Practice Within Longitudinal Infection Prevention and Surveillance von Chen, Donald, Quinn, Moira, Sussner, Rita M., Rowland, Teresa, Rinck, Georgeta, Labrecque, Sophie, Mack, Lynda, Clones, Barbara, Wang, Guiqing, Chanza, Melissa, Huang, Weihua, Scurlock, Corey, Becker, Christian D., Doty, Alan J., Ashworth, Judy L., Fortunato-Habib, Mary M., Wong, Brian E., Holler, Devon J., Hansen, Kyle, Abdolahi, Amir, Carmona, Juan J., Gross, Brian D.

Volltext

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users von Shram, Megan J., Henningfield, Jack E., Apseloff, Glen, Gorodetzky, Charles W., De Martin, Sara, Vocci, Frank L., Sapienza, Frank L., Kosten, Thomas R., Huston, Jeff, Buchhalter, August, Ashworth, Judy, Lanier, Ryan, Folli, Franco, Mattarei, Andrea, Guidetti, Clotilde, Comai, Stefano, O’Gorman, Cedric, Traversa, Sergio, Inturrisi, Charles E., Manfredi, Paolo L., Pappagallo, Marco

Volltext

S158 - Psychedelic Drug Abuse Potential Assessment Challenges to Scientific Validity and Real World Predictiveness: Current Approaches and Research Gaps von Henningfield, Jack, Buchhalter, August, Durgin, Caitlyn, Lanier, Ryan, Ashworth, Judy

Volltext

M134 - A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market von Ashworth, Judy, Davis, Vicki G, Mannion, Richard, Hufford, Michael

Volltext

Psychedelic Drug Abuse Potential Assessment Challenges to Scientific Validity and Real World Predictiveness: Current Approaches and Research Gaps von Henningfield, Jack, Buchhalter, August, Durgin, Caitlyn, Lanier, Ryan, Ashworth, Judy

Volltext

A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market von Ashworth, Judy, Davis, Vicki G, Mannion, Richard, Hufford, Michael

Volltext

Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications von Lanier, Ryan, Bogenschutz, Michael, Schindler, Emmanuelle, Kelmendi, Benjamin, Durgin, Caitlyn, Ashworth, Judy

Volltext

W161 - Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications von Lanier, Ryan, Bogenschutz, Michael, Schindler, Emmanuelle, Kelmendi, Benjamin, Durgin, Caitlyn, Ashworth, Judy

Volltext

The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act von Moline, Margaret, Asakura, Shoji, Beuckman, Carsten, Landry, Ishani, Setnik, Beatrice, Ashworth, Judy, Henningfield, Jack E.

Volltext

Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective von Henningfield, Jack E., Ashworth, Judy, Heal, David J., Smith, Sharon L.

Volltext

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain von Lange, Bernd, Kuperwasser, Brigitte, Okamoto, Akiko, Steup, Achim, Häufel, Thomas, Ashworth, Judy, Etropolski, Mila

Volltext

A comparison among tapentadol tamper‐resistant formulations ( TRF ) and O xy C ontin ® (non‐ TRF ) in prescription opioid abusers von Vosburg, Suzanne K., Jones, Jermaine D., Manubay, Jeanne M., Ashworth, Judy B., Shapiro, Douglas Y., Comer, Sandra D.

Volltext

531. Practical and Evidence-Based Considerations for Implementation of Bacterial Whole-Genome Sequencing Within Longitudinal Infection Control Practice von Chen, Donald S, Quinn, Moira, Sussner, Rita M, Wang, Guiqing, Fallon, John T, Chanza, Melissa, Doty, Alan J, Ashworth, Judy L, Kelleher, Steven W, Holler, Devon J, Fortunato-habib, Mary M, Loving, Joshua, Abdolahi, Amir, Carmona, Juan J, Gross, Brian D

Volltext

Utility of Antinuclear Antibody Screening by Various Methods in a Clinical Laboratory Patient Cohort von Deng, Xiaoli, Peters, Brian, Ettore, Michael W, Ashworth, Judy, Brunelle, Lynn A, Crowson, Cynthia S, Moder, Kevin G, Snyder, Melissa R

Volltext